- Home
- IRWD vs SATX Comparison
IRWD vs SATX Comparison
Compare IRWD & SATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- SATX
- Stock Information
- Founded
- IRWD 1998
- SATX 2012
- Country
- IRWD United States
- SATX Israel
- Employees
- IRWD N/A
- SATX N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- SATX Radio And Television Broadcasting And Communications Equipment
- Sector
- IRWD Health Care
- SATX Technology
- Exchange
- IRWD Nasdaq
- SATX Nasdaq
- Market Cap
- IRWD 150.9M
- SATX 177.6M
- IPO Year
- IRWD 2010
- SATX N/A
- Fundamental
- Price
- IRWD $0.71
- SATX $2.05
- Analyst Decision
- IRWD Buy
- SATX Strong Buy
- Analyst Count
- IRWD 5
- SATX 2
- Target Price
- IRWD $4.94
- SATX $2.25
- AVG Volume (30 Days)
- IRWD 4.0M
- SATX 378.2K
- Earning Date
- IRWD 05-07-2025
- SATX 05-22-2025
- Dividend Yield
- IRWD N/A
- SATX N/A
- EPS Growth
- IRWD N/A
- SATX N/A
- EPS
- IRWD N/A
- SATX N/A
- Revenue
- IRWD $317,676,000.00
- SATX $20,648,000.00
- Revenue This Year
- IRWD N/A
- SATX $50.67
- Revenue Next Year
- IRWD N/A
- SATX $1.64
- P/E Ratio
- IRWD N/A
- SATX N/A
- Revenue Growth
- IRWD N/A
- SATX 92.43
- 52 Week Low
- IRWD $0.59
- SATX $0.53
- 52 Week High
- IRWD $8.23
- SATX $2.39
- Technical
- Relative Strength Index (RSI)
- IRWD 30.30
- SATX 66.42
- Support Level
- IRWD $0.88
- SATX $1.99
- Resistance Level
- IRWD $0.98
- SATX $2.02
- Average True Range (ATR)
- IRWD 0.10
- SATX 0.03
- MACD
- IRWD 0.01
- SATX -0.02
- Stochastic Oscillator
- IRWD 14.47
- SATX 100.00
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd is engaged in developing end-to-end next-generation satellite communication systems. This includes satellite payloads, user terminals, and modems, which are built on powerful in-house designed chipsets. Their products feature modems equipped with Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the entire DVB-RCS2 / DVB-S2X industry standards as well as a complete SDR for any other waveform. The company has a geographical presence in the U.S. & Canada, the UK, and Other countries, with the majority of its revenue generated from the U.S. and Canada.